Sign in
4

Changes in Ownership

Entrada Therapeutics, Inc. Filed Acc 0001104659-21-134772

Director bought 250,000 shares at $20.00 ($5,000,000)

  • Director acquired 3,827,224 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

PARMAR KUSH · Director

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2021-11-02 Conversion : show line 1 in the form +318,616 649,771 I
2021-11-02 Conversion : show line 2 in the form +2,371,739 3,021,510 I
2021-11-02 Conversion : show line 3 in the form +564,217 564,217 I
2021-11-02 Conversion : show line 4 in the form +254,512 3,276,022 I
2021-11-02 Conversion : show line 5 in the form +318,140 882,357 I
2021-11-02 Purchase : show line 6 in the form +250,000 $20.00 $5,000,000 1,132,357 I
Open-market purchases · 250,000 sh · avg $20.00 · $5,000,000

Table II: Derivative

5 lines
Date Transaction Shares Underlying Owned after D/I
2021-11-02 Conversion : show line 7 in the form Series Seed Preferred Stock −318,616 318,616 0 I
2021-11-02 Conversion : show line 8 in the form Series A Preferred Stock −2,371,739 2,371,739 0 I
2021-11-02 Conversion : show line 9 in the form Series A Preferred Stock −564,217 564,217 0 I
2021-11-02 Conversion : show line 10 in the form Series B Preferred Stock −254,512 254,512 0 I
2021-11-02 Conversion : show line 11 in the form Series B Preferred Stock −318,140 318,140 0 I
Loading xslF345X03/tm2132054-3_4seq1.xml…